Detalhe da pesquisa
1.
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
Am J Respir Crit Care Med
; 209(9): 1132-1140, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354066
2.
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.
Am J Respir Crit Care Med
; 209(2): 137-152, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772985
3.
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
Am J Respir Crit Care Med
; 209(4): 362-373, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113442
4.
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Am J Respir Crit Care Med
; 209(6): 647-669, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174955
5.
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Rheumatology (Oxford)
; 63(2): 472-481, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228011
6.
Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.
JAMA
; 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762797
7.
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial.
Thorax
; 78(9): 882-889, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948586
8.
Idiopathic pulmonary fibrosis: state of the art for 2023.
Eur Respir J
; 61(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702498
9.
Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study.
Eur Respir J
; 61(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777776
10.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
Rheumatology (Oxford)
; 62(5): 1877-1886, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173318
11.
Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings.
Eur Radiol
; 33(7): 4746-4757, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786906
12.
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
Am J Respir Crit Care Med
; 205(9): 1084-1092, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050837
13.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Am J Respir Crit Care Med
; 205(6): 674-684, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851799
14.
Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 206(1): 56-69, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417304
15.
A Phase IIb Randomized Clinical Study of an Anti-αvß6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 206(9): 1128-1139, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771569
16.
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities.
Am J Respir Crit Care Med
; 205(7): 795-805, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929108
17.
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.
Am J Respir Crit Care Med
; 206(3): 247-259, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353660
18.
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med
; 205(9): e18-e47, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486072
19.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
N Engl J Med
; 380(26): 2518-2528, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112379
20.
Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028256